Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.028.745 |
Chemical and physical data | |
Formula | C15H16N2O |
Molar mass | 240.306 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class. [1] [2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed. [1] [2]
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.028.745 |
Chemical and physical data | |
Formula | C15H16N2O |
Molar mass | 240.306 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class. [1] [2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed. [1] [2]